Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
Wang Y, Yang C, Song Y, Coleman JR, Stawowczyk M, Tafrova J, Tasker S, Boltz D, Baker R, Garcia L, Seale O, Kushnir A, Wimmer E, Mueller S.
Wang Y, et al. Among authors: song y.
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):e2102775118. doi: 10.1073/pnas.2102775118.
Proc Natl Acad Sci U S A. 2021.
PMID: 34193524
Free PMC article.